Biotechnology Reproductive Biotechnology Law In Russia.
1. Introduction
Reproductive biotechnology law in Russia concerns the legal regulation of medical technologies and scientific procedures used to assist human reproduction. It covers artificial insemination, in-vitro fertilisation (IVF), embryo creation and preservation, gamete donation, surrogacy, reproductive genetic testing, and the legal status of children born through assisted reproductive technologies (ART).
Russia has developed a legal framework that combines constitutional rights, family law, healthcare legislation, bioethics, and civil-law principles.
The principal legal challenge is balancing three interests:
The reproductive autonomy and family rights of individuals.
The protection of embryos, donors, surrogate mothers, and children.
State regulation of medical technologies, reproductive services, and genetic information.
Russian reproductive biotechnology law is particularly significant because it distinguishes between access to assisted reproduction, ownership and disposition of reproductive materials, parental status, and the commercial or non-commercial use of surrogacy.
2. Constitutional and legislative framework
The principal sources of Russian reproductive biotechnology law are:
| Legislation | Legal significance |
|---|---|
| Constitution of the Russian Federation, 1993 | Protection of dignity, privacy, family, motherhood and childhood |
| Family Code No. 223-FZ of 29 December 1995 | Parentage, maternity, paternity and children's rights |
| Federal Law No. 323-FZ of 21 November 2011 | Healthcare regulation and assisted reproductive technologies |
| Federal Law No. 143-FZ of 15 November 1997 | Civil registration of births and parentage |
| Federal Law No. 538-FZ of 19 December 2022 | Major amendments restricting eligibility for surrogacy |
| Ministry of Health Order No. 803n of 31 July 2020 | Clinical procedures and restrictions governing ART |
The most important provision is Article 55 of Federal Law No. 323-FZ, which regulates assisted reproductive technologies.
minzdrav.gov.ru+3
3. Constitutional protection of reproductive rights
The Russian Constitution provides the broader foundation for reproductive medicine.
Article 21 – Human dignity
Human dignity must be protected. This principle is relevant to reproductive treatment, embryo handling, medical experimentation, and the prohibition of degrading treatment.
Article 23 – Privacy and personal life
Individuals enjoy protection of private and family life. Reproductive decisions, infertility treatment, genetic information, and medical records may fall within this protection.
Article 38 – Family, motherhood and childhood
The Constitution protects motherhood, childhood, and the family. This provision is important when courts determine parental status and the interests of children born through reproductive biotechnology.
Article 41 – Right to health protection
Citizens have a constitutional right to health protection and medical assistance.
These constitutional provisions must be read together with healthcare legislation. They do not, by themselves, create an unrestricted right to every reproductive technology.
4. Assisted reproductive technologies under Article 55
Article 55 of Federal Law No. 323-FZ recognises assisted reproductive technologies as methods of treating infertility in which some or all stages of conception and early embryonic development take place outside the woman's body.
The legislation covers several procedures:
In-vitro fertilisation (IVF).
Artificial insemination.
Use of donor sperm and eggs.
Embryo donation.
Cryopreservation of gametes and embryos.
Embryo implantation.
Gestational surrogacy.
Eligibility and consent
Article 55 recognises the right of married and unmarried men and women to use ART with mutual informed voluntary consent. A single woman may also use ART with her informed consent.
However, access to ordinary ART must be distinguished from access to surrogacy, which is subject to additional statutory restrictions introduced in 2022.
minzdrav.gov.ru+1
5. In-vitro fertilisation (IVF) and embryo regulation
IVF is one of the most important reproductive biotechnology procedures recognised under Russian law.
The procedure generally involves:
Medical examination of the prospective parents.
Ovarian stimulation, where medically appropriate.
Collection of eggs.
Collection and preparation of sperm.
Fertilisation in a laboratory.
Embryo development and assessment.
Embryo transfer or cryopreservation.
Legal requirements
Article 55 establishes several important safeguards:
Medical intervention requires informed voluntary consent.
Gametes and embryos may be cryopreserved and stored using legally permitted funding.
Human reproductive cells, reproductive-organ tissues, and embryos cannot be used for industrial purposes.
Selection of the future child's sex is prohibited, except where necessary to avoid inheritance of sex-linked diseases.
These provisions are intended to prevent reproductive biotechnology from becoming an unrestricted commercial or industrial activity.
minzdrav.gov.ru+1
6. Gamete donation and reproductive material
Russian law permits the use of donor reproductive materials under regulated medical conditions.
Article 55(7) establishes the following eligibility requirements for reproductive-cell donors:
Age between 18 and 35 years.
Physical health.
Mental health.
Completion of medical and genetic examinations.
Article 55(8) provides recipients with access to specified information about donors, including medical and genetic examination results, race, nationality, and external characteristics.
The legal framework therefore attempts to balance the recipient's interest in medical information with the protection of donor confidentiality.
Important legal distinction: A gamete donor is not automatically treated as the legal parent of a child merely because their reproductive material was used in conception. Legal parentage is determined under the Family Code and applicable birth-registration rules.
7. Surrogacy regulation in Russia
Surrogacy is one of the most legally significant and controversial areas of Russian reproductive biotechnology.
Article 55(9) of Federal Law No. 323-FZ recognises gestational surrogacy through a contractual arrangement between a surrogate mother and eligible intended parents.
The surrogate carries and gives birth to a child following embryo transfer.
Conditions for surrogate mothers
Article 55(10) provides that a surrogate mother must:
Be between 20 and 35 years old.
Have at least one healthy biological child of her own.
Obtain a medical certificate confirming satisfactory health.
Give written informed voluntary consent.
Obtain written consent from her husband if she is married.
Not simultaneously act as the egg donor for the same arrangement.
Restrictions introduced by Federal Law No. 538-FZ of 2022
The 2022 amendments substantially changed the eligibility rules.
Under the revised Article 55:
Intended parents using surrogacy must satisfy the statutory medical and family-status requirements.
A couple must be legally married.
The couple must satisfy the genetic-parentage requirements prescribed by law.
A single woman may qualify where she meets the medical and genetic requirements.
Foreign citizens cannot use Russian surrogacy arrangements under the amended nationality restrictions.
These restrictions distinguish Russia's present framework from its earlier, more internationally accessible surrogacy system.
Consultant Plus+2
8. Legal parentage and birth registration
Legal parentage is one of the most complicated aspects of reproductive biotechnology.
The relevant provisions are Articles 47, 48, 51 and 52 of the Russian Family Code.
Article 51(4): Parentage following assisted reproduction
Married persons who have given written consent to artificial fertilisation or embryo implantation are registered as the child's parents.
Where an embryo is implanted in a surrogate mother, the intended parents may be registered as parents only with the consent of the woman who gave birth.
Article 52: Challenging parentage
Article 52 regulates judicial challenges to maternity and paternity.
It also prevents a spouse who consented to assisted reproduction from challenging paternity merely by relying on the fact that artificial fertilisation or embryo implantation was used.
Once the intended parents have been registered following surrogacy, the statutory restrictions also prevent them and the surrogate mother from subsequently challenging parentage on the basis of the circumstances of the embryo implantation.
WIPO+1
9. Important Russian case laws and judicial decisions
Russian reproductive biotechnology law has been shaped by decisions of the Constitutional Court and the Supreme Court, particularly concerning surrogacy, genetic parentage, consent, and children's welfare.
Case 1. Constitutional Court of Russia – Decision No. 880-O of 15 May 2012
Subject: Surrogate mother's consent and parental registration.
Facts:
A married couple entered into a surrogacy agreement with a woman who agreed to carry an embryo created using the couple's reproductive material.
After becoming pregnant, the surrogate withdrew from the arrangement. Following childbirth, she refused to consent to the registration of the genetic parents as the child's legal parents.
The intended parents approached the courts seeking recognition of their parental status.
Legal issue:
Whether the requirement for the surrogate mother's consent to the registration of intended parents violated the constitutional rights of the genetic parents.
Decision:
The Constitutional Court refused to accept the constitutional complaint for consideration.
The dispute concerned the application of Article 51(4) of the Family Code and the statutory requirement for the surrogate mother's consent.
Legal significance:
Genetic parentage does not automatically override the statutory birth-registration procedure.
The surrogate mother's consent has an important legal role.
Reproductive agreements do not automatically guarantee parental registration.
Disputes involving surrogate children require consideration of applicable family-law protections.
This decision should not be interpreted as a comprehensive constitutional judgment on every aspect of surrogacy.
ГАРАНТ+1
Case 2. Supreme Court of Russia – Plenary Resolution No. 16 of 16 May 2017
Subject: Disputes arising from assisted reproductive technologies.
This is one of the most important judicial authorities in Russian reproductive biotechnology law.
The Supreme Court provided guidance on disputes involving artificial fertilisation, embryo implantation, donor genetic material, and surrogacy.
Important legal principles:
Written consent to artificial fertilisation or embryo implantation establishes the basis for registering the consenting married persons as parents.
A spouse who consented to ART cannot challenge paternity simply because reproductive technology was used.
Courts must investigate whether consent was voluntary, informed, valid for the relevant period, and withdrawn before treatment.
Where donor reproductive material is used, the donor does not automatically acquire parental rights.
Where a surrogate refuses consent to the registration of intended parents, the refusal is not an automatic reason to dismiss their claim.
The Supreme Court instructs courts to examine the surrogacy contract, the genetic relationship, the circumstances of the surrogate's refusal, and the child's interests.
Legal significance:
Resolution No. 16 establishes that reproductive biotechnology disputes must be decided through a combination of statutory parentage rules and the best interests of the child.
Consultant Plus+1
Case 3. Paradiso and Campanelli v. Italy (2017), European Court of Human Rights
International comparative authority – not a Russian domestic judgment
Subject: International surrogacy and legal recognition of parent-child relationships.
Facts:
An Italian couple travelled to Russia and entered into a surrogacy arrangement. A child was born in Russia, and the intended parents were identified in the Russian birth documentation.
Italian authorities subsequently questioned the parentage arrangement and removed the child from the couple's care.
Legal issue:
Whether the Italian authorities' actions violated the applicants' right to respect for private and family life under Article 8 of the European Convention on Human Rights.
Decision:
The Grand Chamber of the European Court of Human Rights found no violation of Article 8 in the circumstances of the case.
The Court considered the absence of a biological relationship, the short duration of the relationship between the applicants and the child, and the public authorities' assessment of the circumstances.
Legal significance for Russian reproductive biotechnology:
International surrogacy can create conflicts between domestic family-law systems.
Birth registration in one country does not necessarily guarantee recognition of parentage in another.
Biological connections and the child's welfare can become important in international disputes.
Cross-border reproductive arrangements require careful consideration of citizenship, nationality, and parentage laws.
The judgment concerned Italy's actions, not the validity of Russian surrogacy legislation.
HUDOC+1
10. Clinical regulation of reproductive biotechnology
Russian reproductive medicine is also regulated through Ministry of Health Order No. 803n of 31 July 2020.
This order establishes the procedure for using assisted reproductive technologies, including medical requirements, contraindications, and restrictions.
It is important because Article 55 of Federal Law No. 323-FZ establishes the statutory framework, while Order No. 803n provides clinical and procedural requirements.
Relevant compliance issues include:
Patient examination and diagnosis.
Medical indications for reproductive treatment.
Informed consent and medical documentation.
Donor screening.
Embryo handling and cryopreservation.
Laboratory quality and safety procedures.
Medical supervision and treatment records.
Medical organisations must also comply with the applicable licensing requirements for medical activities.
knd.ac.gov.ru+1
11. Genetic testing and preimplantation genetic diagnosis
Genetic testing is increasingly important in reproductive biotechnology.
Preimplantation genetic testing (PGT) allows medical specialists to examine embryos for particular genetic or chromosomal abnormalities before implantation.
Its potential applications include:
Identifying certain inherited genetic disorders.
Assessing chromosomal abnormalities.
Supporting reproductive decisions involving hereditary disease risks.
Reducing the likelihood of transmitting certain genetic conditions.
However, reproductive genetic testing must be distinguished from unrestricted genetic selection.
Article 55(4) prohibits selection of the future child's sex except where necessary to avoid inheritance of sex-linked diseases.
The use of genetic information also raises privacy, medical confidentiality, informed-consent, and discrimination concerns.
Important qualification: Russian law does not provide an unrestricted general authorisation for selecting embryos according to preferred physical, behavioural, or social characteristics. The legal basis and medical justification for each procedure must be assessed separately.
12. Embryo preservation and cryopreservation
Article 55(5) recognises the right of citizens to cryopreserve and store reproductive cells, reproductive-organ tissues, and embryos.
Cryopreservation has important legal consequences because reproductive material may remain stored for extended periods.
Common legal disputes concern:
Withdrawal of consent to continued storage.
Disagreement between former spouses.
Death of one reproductive-material provider.
Transfer of embryos between medical institutions.
Storage fees and contractual responsibilities.
Disposal or further use of stored embryos.
The law expressly recognises storage rights, but it does not resolve every possible dispute involving jointly created embryos. Such disputes may require examination of consent documents, medical agreements, and applicable civil and family law.
13. Legal protection of reproductive privacy and genetic data
Reproductive biotechnology involves highly confidential personal information, including:
Fertility and infertility records.
Genetic test results.
Embryo-development information.
Donor medical histories.
Reproductive treatment records.
Information about pregnancy and childbirth.
The principal legal framework includes Federal Law No. 152-FZ of 27 July 2006 on Personal Data and Federal Law No. 323-FZ on healthcare.
Genetic and medical information requires appropriate protection against unauthorised disclosure.
Potential legal violations include:
Disclosure of donor identity without a lawful basis.
Unauthorised access to IVF records.
Improper transfer of genetic information.
Misuse of reproductive information by clinics.
Disclosure of surrogate pregnancy information.
Improper processing of patients' personal information.
These issues may result in civil, administrative, or other legal consequences depending on the nature of the violation.
14. Liability for violations of reproductive biotechnology law
Russian law provides several routes for addressing unlawful conduct in reproductive medicine.
| Violation | Potential legal consequences |
|---|---|
| Medical negligence during IVF | Civil liability and compensation |
| Treatment without valid consent | Medical and civil liability |
| Breach of medical confidentiality | Liability under applicable privacy laws |
| Improper embryo handling | Medical regulatory and civil consequences |
| Unlicensed medical services | Administrative or criminal consequences, depending on circumstances |
| Fraudulent surrogacy agreements | Civil and potentially criminal liability |
| Improper donor screening | Regulatory and civil consequences |
| Falsification of medical records | Potential criminal liability |
Relevant legal provisions include:
Article 1064 of the Civil Code – General liability for causing harm.
Article 1095 of the Civil Code – Liability for harm caused by defects in goods, work, or services.
Article 151 of the Civil Code – Compensation for moral damage.
Article 13.14 of the Code of Administrative Offences – Disclosure of information with restricted access in circumstances covered by the provision.
Article 137 of the Criminal Code – Violation of privacy.
Article 235 of the Criminal Code – Illegal medical or pharmaceutical activity in circumstances covered by the provision.
Liability depends on the facts, the applicable statutory elements, and proof of the relevant violation.
15. Major legal challenges in Russian reproductive biotechnology
Several unresolved or developing issues deserve particular attention.
A. Embryo ownership and control
Russian legislation recognises the storage of embryos but does not provide a complete property-law framework for every dispute involving jointly created embryos.
B. Surrogacy contractual disputes
Disagreements can arise over compensation, medical expenses, pregnancy complications, and the transfer of the child after childbirth.
C. Genetic parentage conflicts
Genetic parentage, gestational motherhood, and legal parentage are not necessarily identical. This distinction creates complicated legal disputes.
D. Cross-border reproductive treatment
A reproductive arrangement lawful in Russia may not automatically be recognised in another country.
E. Reproductive genetic technologies
Developments in embryo screening and genetic testing create questions about medical necessity, discrimination, privacy, and the limits of permissible selection.
F. Children's rights
The child's right to family life, identity, care, and legal parentage must be considered when resolving reproductive disputes.
16. Critical analysis of Russian reproductive biotechnology law
The Russian legal system has adopted a combination of statutory regulation and judicial supervision.
Its framework has several important characteristics:
ART is expressly recognised as a method of infertility treatment.
IVF and reproductive-material preservation are legally regulated.
Gamete donation is permitted subject to statutory requirements.
Surrogacy is permitted but subject to significant eligibility restrictions.
Legal parentage is governed by the Family Code.
Courts have an important role in resolving disputes involving surrogate mothers and intended parents.
However, several areas require continued legal development.
In particular, embryo disposition, posthumous reproduction, international recognition of parentage, reproductive genetic testing, and contractual disputes involving medical complications require careful legislative and judicial attention.
The 2022 surrogacy amendments also demonstrate that reproductive biotechnology is not governed exclusively by individual reproductive autonomy: nationality, marital status, genetic parentage, and public policy are important statutory considerations.
17. Conclusion
Reproductive biotechnology law in Russia represents an important intersection of medical science, constitutional law, family law, civil liability, and bioethics.
Federal Law No. 323-FZ, particularly Article 55, provides the principal legal foundation for assisted reproductive technologies. The Russian Family Code determines legal parentage, while Ministry of Health Order No. 803n regulates important clinical aspects of reproductive treatment.
The Supreme Court's Plenary Resolution No. 16 of 16 May 2017 is especially significant because it provides judicial guidance on IVF, donor reproduction, surrogacy, and parental registration.
The Constitutional Court's Decision No. 880-O of 15 May 2012 and the comparative European judgment in Paradiso and Campanelli v. Italy further illustrate the difficulties of balancing genetic parentage, surrogate motherhood, and children's rights.
Ultimately, the central objective of Russian reproductive biotechnology law is to regulate scientific progress while protecting human dignity, reproductive health, family relationships, and the legal interests of children.
18. Important legal authorities for academic research
| Authority | Relevant subject |
|---|---|
| Constitution, Articles 21, 23, 38 and 41 | Dignity, privacy, family and health |
| Family Code, Articles 47–52 | Legal parentage |
| Federal Law No. 323-FZ, Article 55 | Assisted reproductive technologies |
| Federal Law No. 538-FZ (2022) | Surrogacy amendments |
| Federal Law No. 143-FZ (1997) | Birth registration |
| Ministry of Health Order No. 803n (2020) | ART procedures |
| Supreme Court Plenary Resolution No. 16 (2017) | ART-related parentage disputes |
| Constitutional Court Decision No. 880-O (2012) | Surrogate mother's consent |
Primary research sources
Russian Federal Law No. 323-FZ – Ministry of Health.
Article 55 – Current statutory text.
Supreme Court Resolution No. 16 – ART disputes.
Supreme Court Resolution No. 16 – English text.
Constitutional Court Decision No. 880-O.
Ministry of Health Order No. 803n.
Legal research note: This explanation reflects the statutory materials available as of 18 November 2026. In particular, the 2022 surrogacy amendments should be applied with their transitional provisions. A foreign national is not automatically eligible for Russian surrogacy: at least one intended genetic parent must be a Russian citizen, and the surrogate must also satisfy the Russian citizenship requirement. This is not a blanket prohibition on every mixed-nationality couple.

comments